| Title: | Regular use of aspirin and statins reduces the risk of cancer in individuals with systemic inflammatory diseases. |
| Journal: | Cancer Research |
| Published: | 27 Mar 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38536116/ |
| DOI: | https://doi.org/10.1158/0008-5472.can-23-2941 |
Publication 10024
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Aspirin has shown potential for cancer prevention, but a recent large randomized controlled trial found no evidence for a reduction in cancer risk. Given the anti-inflammatory effects of aspirin, systemic inflammatory diseases (SIDs), such as osteoporosis, cardiovascular diseases, and metabolic diseases, could potentially modify the aspirin-cancer link. To investigate the impact of aspirin in people with SIDs, we conducted an observational study on a prospective cohort of 478,615 UK Biobank participants. Individuals with at least one of the 41 SIDs displayed a higher cancer risk than those without SIDs. Regular aspirin use showed protective effects exclusively in patients with SID, contrasting an elevated risk among their non-SID counterparts. Nonetheless, aspirin use demonstrated preventative potential only for 9 of 21 SID-associated cancer subtypes. Cholesterol emerged as another key mediator linking SIDs to cancer risk. Notably, regular statin use displayed protective properties in patients with SID but not in their non-SID counterparts. Concurrent use of aspirin and statins exhibited a stronger protective association in patients with SID, covering 14 common cancer subtypes. In summary, patients with SIDs may represent a population particularly responsive to regular aspirin and statin use. Promoting either combined or individual use of these medications within the context of SIDs could offer a promising chemoprevention strategy.</p>
12 Authors
- Jia-Run Lin
- Duan-Duan Han
- Wei Wei
- Qin Zeng
- Zi-Xuan Rong
- Xue Bai
- Yan-Pei Zhang
- Jian Wang
- Xiao-Ting Cai
- Xu-Guang Rao
- Si-Cong Ma
- Zhong-Yi Dong
Enabling scientific discoveries that improve human health